Stone disease, also called urolithiasis or nephrolithiasis, refers to the formation of hard mineral deposits in the urinary tract and affects roughly one in eight men and one in seventeen women over a lifetime. The condition has been documented in humans for thousands of years, and its prevalence has been climbing in developed countries over the past century. What makes stone disease particularly frustrating is its tendency to come back: understanding your stone type, the metabolic conditions that drive it, and the surprisingly simple steps that reduce recurrence can make the difference between a single painful episode and a chronic pattern.
The Main Types of Kidney Stones
Not all kidney stones are made of the same stuff, and the composition matters because it shapes both the treatment approach and the prevention strategy. The overwhelming majority fall into a few categories.
Calcium oxalate stones are the most common variety. They come in two crystal forms: monohydrate (COM) and dihydrate (COD). These might sound like trivial distinctions, but a large cohort study found that patients with predominantly COD stones had a five-year surgical recurrence rate about 47% higher than COM patients, along with higher urine calcium levels and lower citrate levels.1PubMed. Calcium Oxalate Monohydrate and Dihydrate Stone Formers: Differing Surgical Recurrence Rates and Metabolic Profiles in a Large Cohort In other words, the crystal structure of a calcium oxalate stone can predict how aggressively it will return.
Calcium phosphate stones form in a related but distinct environment. People who form these tend to have higher urine pH compared with calcium oxalate stone formers.2PubMed Central. Urine pH and Citrate as Predictors of Calcium Phosphate Stone Formation That alkaline urine shifts the chemistry toward phosphate-based crystals rather than oxalate-based ones. Some people form mixed stones containing both oxalate and phosphate components.
Uric acid stones account for a smaller but significant share. The main driver here is the opposite problem: urine that is too acidic. When urine pH drops below about 5.5, uric acid stops dissolving and starts precipitating into crystals.3Kidney International. Studies on the pathophysiology of the low urine pH in patients with uric acid stones Low urine volume and excess uric acid in the urine compound the risk.4Journal of Nephrology. Epidemiology and clinical pathophysiology of uric acid kidney stones Unlike calcium stones, uric acid stones can sometimes be dissolved with medications that raise urine pH, which gives them a unique treatment angle.
Struvite stones, sometimes called infection stones, form as a direct result of urinary tract infections caused by bacteria that produce an enzyme called urease. Proteus mirabilis is the most well-known culprit. The enzyme breaks down urea in the urine, producing ammonia that makes the urine more alkaline. That alkaline environment triggers the formation of struvite and carbonate apatite crystals.5Microbiological Research. Inhibition of crystallization caused by Proteus mirabilis during the development of infectious urolithiasis by various phenolic substances These stones can grow rapidly and become large “staghorn” stones that fill the interior of the kidney.
Cystine stones are the rarest major type and are caused by an inherited disorder called cystinuria. In this condition, the kidneys fail to properly reabsorb cystine, an amino acid, from the urine. Cystine is poorly soluble, so when it accumulates it forms stones.6Nature Reviews Nephrology. Pathophysiology and treatment of cystinuria The disorder is autosomal recessive in most cases. Genetic studies estimate that monogenic kidney stone disorders, including cystinuria, account for roughly 15% of patients seen at stone clinics.7Nature Reviews Urology. Genetics of kidney stone disease
How Stones Actually Form Inside the Kidney
Knowing the ingredients of a stone only tells half the story. The process by which minerals go from dissolved in urine to a solid mass stuck inside the kidney involves a chain of events that researchers have been piecing together for decades.
For the most common calcium oxalate stones, the story often begins with something called Randall’s plaque. These are tiny deposits of calcium phosphate that build up in the tissue lining the inner surface of the kidney, specifically in the basement membranes of thin loops of Henle. Electron microscopy has shown these deposits can be as small as 50 nanometers.8Journal of Clinical Investigation. Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle Over time, the plaque grows and eventually erodes through the tissue surface, becoming exposed to the urine flowing through the kidney. Once exposed, these calcium phosphate patches act as a seed for calcium oxalate crystals to attach and grow into a full stone.9PubMed Central. The role of Randall plaques on kidney stone formation Large amounts of Randall’s plaque appear to be unique to people who form calcium oxalate stones, making it a key part of the puzzle for this stone type.10Kidney International. Randall’s plaque: Pathogenesis and role in calcium oxalate nephrolithiasis
Whether crystals in the urine grow into stones or get harmlessly flushed away depends on a tug-of-war between promoters and inhibitors. On the promoter side: low urine volume, high concentrations of calcium, oxalate, sodium, and urate, and acidic or alkaline pH depending on the stone type. On the inhibitor side: citrate, magnesium, zinc, and various proteins and organic molecules that coat crystal surfaces and prevent them from growing or sticking to kidney tissue.11EAU-EBU Update Series. The Role of Urinary Kidney Stone Inhibitors and Promoters in the Pathogenesis of Calcium Containing Renal Stones Citrate is especially important; it binds to calcium in the urine, reducing the amount available to pair with oxalate, and it directly inhibits crystal growth.12PubMed Central. Kidney stone matrix proteins: Role in stone formation
The behavior of proteins in this process is surprisingly double-edged. Certain large molecules with negatively charged groups can inhibit crystal growth by coating crystal surfaces, and they can steer calcium oxalate crystallization toward the dihydrate form, which is less stable and less prone to stone formation. But those same molecules can also promote stone formation under different conditions by helping crystals stick to kidney cell surfaces or by clumping together into aggregates.13PubMed Central. The Role of Macromolecules in the Formation of Kidney Stones This dual nature helps explain why stone disease is so variable from person to person: the same biological machinery can push the outcome in either direction.
Risk Factors That Drive Stone Formation
Several modifiable and non-modifiable factors stack the odds toward stone formation. Diet is among the most studied. A systematic review and meta-analysis of protein intake found that higher consumption of nondairy animal protein, total meat, and processed meat were all associated with increased stone risk. Each additional 100 grams of red meat per day was linked to about a 39% higher risk of kidney stones. Dairy protein, however, showed the opposite association, with higher dairy intake slightly reducing risk.14PubMed Central. Associations of Total Protein or Animal Protein Intake and Animal Protein Sources with Risk of Kidney Stones: A Systematic Review and Dose-Response Meta-Analysis The difference probably comes down to how different protein sources affect urine chemistry: animal protein from meat raises acid load and uric acid excretion, while dairy delivers calcium that binds oxalate in the gut and prevents its absorption.
Metabolic syndrome, the cluster of conditions including high blood sugar, high blood pressure, and obesity, raises stone risk through multiple channels. High blood sugar increases the amount of calcium, uric acid, phosphorus, and oxalate the kidneys dump into the urine. Insulin resistance lowers urine pH and reduces ammonia production, both of which favor stone formation.15PubMed Central. Metabolic Syndrome Increases the Risk of Kidney Stone Disease: A Cross-Sectional and Longitudinal Cohort Study This connection partly explains why stone disease rates have been rising alongside obesity rates in many countries.
Bariatric surgery presents a paradox. Although it improves many metabolic outcomes, malabsorptive procedures like Roux-en-Y gastric bypass increase the risk of kidney stones.16PubMed Central. Risk Factors for Kidney Stone Formation following Bariatric Surgery The mechanism is straightforward: the surgery changes how the gut absorbs nutrients, leading to higher oxalate levels in urine, lower citrate, and reduced urine volume. One study comparing post-bypass patients to obese controls found the prevalence of high urine oxalate was about 47% in surgical patients versus around 11% in controls, while low citrate affected 63% of surgical patients versus just 5% of controls.17PubMed Central. Hypocitraturia and Hyperoxaluria After Roux-en-Y Gastric Bypass Surgery If you have had or are considering bariatric surgery, this is worth discussing with your surgeon and a nephrologist.
Genetics play a larger role than most people realize. Beyond the monogenic disorders like cystinuria, genetic studies have identified polygenic risk factors involving transporters and channels for ions and amino acids, vitamin D metabolism, oxalate metabolism, and purine pathways.7Nature Reviews Urology. Genetics of kidney stone disease If your parents or siblings have had stones, your own risk is elevated regardless of your diet or hydration habits.
Symptoms and What to Expect
A stone sitting quietly in the kidney may cause no symptoms at all. The classic agony of renal colic begins when a stone dislodges and starts traveling down the ureter, the narrow tube connecting the kidney to the bladder. The pain is often described as one of the worst experiences a person can have. It radiates to the flank and sometimes down to the groin, and it tends to come in waves rather than staying constant. Other common symptoms include nausea, vomiting, blood in the urine, painful urination, and occasionally chills and fever if an infection is present.18PubMed Central. Hematuria as a Sign of Kidney Stone Disease Evaluated Using Computed Tomography: A Review
The good news is that up to 80% of stones pass on their own without surgical intervention. The likelihood of spontaneous passage depends mainly on stone size: small stones under five or six millimeters usually pass, while larger ones are more likely to get stuck and need help. Men tend to develop their first stone episode between their twenties and a peak around age 40 to 60. Women tend to peak a bit younger, around their late twenties. The gender gap in stone disease has been narrowing over time, with one study showing the male-to-female ratio dropped from about 1.7 to 1 down to 1.3 to 1 over five years.19BMJ. Management of renal colic
How Stones Are Found
When someone shows up in an emergency room with suspected kidney stones, the two main imaging options are ultrasound and CT scan. CT has traditionally been considered the gold standard because it is extremely sensitive and can detect nearly all stone types and sizes. But a landmark randomized trial published in the New England Journal of Medicine found that starting with ultrasound rather than CT led to significantly lower radiation exposure without any meaningful difference in diagnostic accuracy, complication rates, pain scores, return visits, or hospitalizations.20PubMed. Ultrasonography versus Computed Tomography for Suspected Nephrolithiasis That finding shifted clinical practice: many emergency departments now start with ultrasound for suspected stones, reserving CT for cases where the diagnosis remains uncertain or a complication is suspected.
When clinical probability scoring is applied, the practical gap between the two imaging methods narrows further. In patients with a high clinical probability of stones, one study using Bayesian analysis found no significant advantage of CT over ultrasound.21PubMed. Bayesian comparative assessment of diagnostic accuracy of low-dose CT scan and ultrasonography in the diagnosis of urolithiasis after the application of the STONE score CT still has an edge in low- and moderate-probability scenarios where the diagnosis is genuinely uncertain, but for the patient presenting with textbook renal colic symptoms, ultrasound is often sufficient.
Treatment When Stones Do Not Pass on Their Own
When a stone is too large or stuck, three procedures dominate the landscape. Shock wave lithotripsy (SWL) uses focused sound waves delivered from outside the body to shatter a stone into fragments small enough to pass. Ureteroscopy (URS) involves threading a thin scope up through the urethra and bladder into the ureter or kidney, where a laser breaks the stone apart. Percutaneous nephrolithotomy (PNL) is a more involved surgical procedure in which a small channel is created through the back directly into the kidney, used for very large or complex stones.
The choice among these depends mainly on stone size and location. For stones larger than 10 millimeters, particularly in the lower part of the kidney, PNL and ureteroscopy are substantially more effective than shock wave lithotripsy. A meta-analysis found that PNL achieved about double the stone-free rate of SWL for these larger lower-pole stones, and ureteroscopy also outperformed SWL, though by a smaller margin. For stones 10 millimeters and smaller, the advantage of the more invasive approaches shrank considerably.22European Urology. Systematic Review and Meta-analysis of the Clinical Effectiveness of Shock Wave Lithotripsy, Retrograde Intrarenal Surgery, and Percutaneous Nephrolithotomy for Lower-pole Renal Stones
Ureteroscopy also appears to carry a lower need for repeat procedures. A large comparative study found that after adjusting for patient differences, the estimated probability of needing a repeat intervention was about 11% after SWL versus only 0.3% after ureteroscopy.23PubMed Central. Comparative Effectiveness of Shock Wave Lithotripsy and Ureteroscopy for Treating Patients with Kidney Stones That gap is partly why ureteroscopy has been steadily gaining favor over SWL in clinical practice, particularly for mid-sized stones where both approaches are technically feasible.
Prevention Strategies That Work
Fluid intake is the single most consistently supported preventive measure. A Cochrane systematic review found that drinking enough water to produce at least two liters of urine per day cut stone recurrence roughly in half, though the evidence was rated low-certainty because only one well-designed trial met the review’s inclusion criteria.24PubMed Central. Water for preventing urinary stones Observational evidence supports pushing that goal even higher; a dose-response meta-analysis of observational studies suggested that achieving at least 2.5 liters of urine output per day is protective.25PubMed Central. Self-Fluid Management in Prevention of Kidney Stones: A PRISMA-Compliant Systematic Review and Dose-Response Meta-Analysis of Observational Studies A practical rule of thumb: if your urine is pale yellow throughout the day, you are probably drinking enough.
Dietary changes are tailored to stone type but share some common themes. Reducing sodium intake lowers urine calcium excretion. Eating adequate calcium from food (not supplements) actually helps prevent calcium oxalate stones by binding dietary oxalate in the gut before it reaches the kidneys. Limiting red and processed meat intake reduces uric acid production and lowers the acid load on the kidneys. And increasing fruits and vegetables raises citrate levels and urine pH.
When dietary measures are not enough, several medications have proven track records. Thiazide diuretics lower calcium excretion in the urine and are widely used for recurrent calcium stone formers. Citrate supplements, usually as potassium citrate, raise urine citrate and pH, addressing two stone-promoting factors at once. Allopurinol reduces uric acid production and has shown significant benefit in people with calcium stones driven by excess urinary uric acid.26PubMed. Prevention of renal stone disease recurrence. A systematic review of contemporary pharmaceutical options The AUA guideline recommends metabolic testing for high-risk or recurrent stone formers so that treatment can be matched to the specific abnormalities in their urine chemistry.27PubMed. Medical management of kidney stones: AUA guideline
Stones During Pregnancy
Pregnancy changes the urinary tract in ways that might be expected to promote stones: the kidneys filter more blood, calcium excretion rises, and the ureters dilate and slow down. A large study tracking the risk of symptomatic stones relative to non-pregnant women found that risk was normal during the first trimester, roughly doubled during the second trimester, and nearly tripled during the third trimester. The risk peaked at about 3.5 times normal in the first three months after delivery before returning to baseline by one year postpartum.28PubMed Central. Risk of Symptomatic Kidney Stones During and After Pregnancy Interestingly, having had a prior pregnancy was also associated with a modestly higher chance of a first-time symptomatic stone even years later. Management during pregnancy is complicated by the need to avoid radiation from CT scans and the limitations on which medications and procedures are safe for the fetus, making ultrasound the default imaging tool and conservative management the first-line approach.
A Disease with Ancient Roots
Stone disease is not a modern affliction. Archaeological evidence shows that humans have been forming bladder and kidney stones for centuries. What has changed is the pattern: bladder stones were far more common in earlier eras, likely related to nutritional deficiencies and chronic dehydration, whereas kidney stones have become dominant over the past century in wealthier countries.29PubMed Central. History, epidemiology and regional diversities of urolithiasis That shift tracks with changes in diet, particularly rising protein and sodium intake, increasing rates of obesity and diabetes, and possibly climate change increasing insensible fluid losses in warmer regions. In developing countries, bladder stones in children remain more common, often linked to malnutrition and chronic infections. The geography of stone disease tells a story about how profoundly diet, metabolism, and environment shape what happens inside the human kidney.